Clinical trial
An Important Index on Severity of Coronavirus Disease: Erythrocyte Haemoglobin Concentration
NCT04377607 is registered in ClinicalTrials.gov with Nevsehir Public Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Important Index on Severity of Coronavirus Disease: Erythrocyte Haemoglobin Concentration
- Lead sponsor
- Nevsehir Public Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 1, 2020
- Completion date
- December 30, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corona virus infection